BRCA1 and cancer: Nevertheless, the founder mutation BRCA1 ex9-12del was absent in our study likely because we have samples from sporadic cancer patients from the Northeast of Mexico, in comparison with other studies that include patients with hereditary history of cancer and are from central Mexico (Mexico City and Puebla State), the region of origin of this founder mutation [39,40,41].